Tweenvest Stocks

Lukas Biomedical Inc. (TPEX: 6814)

Health Care · Biotechnology · TW

NT$19.00

+2.70% today · -31.8% 1Y

Lukas Biomedical Inc. (TPEX: 6814) operates in the Biotechnology industry within the Health Care sector. The company is valued at $24.52M and employs 87 people.

Over the last twelve months the share price has lost 31.8%, trading between 16.95 and 32.50.

Tweenvest scores Lukas Biomedical Inc. across four factors: quality 55/100, value 47/100, growth 0/100. Its strongest factor is quality.

6814 price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$24.52M
Revenue (TTM)
$5.34M
P/E
—
EPS
-2.20
Dividend yield
—
Beta (5Y)
0.06
52-week high
NT$32.50
52-week low
NT$16.95
Avg volume (3M)
—
Shares outstanding
41.87M
Employees
87
Next earnings
—

About Lukas Biomedical Inc.

Founded in 2002 and headquartered in New Taipei, Taiwan, Lukas Biomedical Inc. primarily develops immune cell medical technologies. These innovations are utilized for regenerative medicine and as complementary treatments for cancer. The company's operations are segmented into four distinct areas: E-commerce, Medical Management Business, Cell Product, and Pharmaceutical Market. Furthermore, it diversifies its business by wholesaling and retailing cosmetics, alongside providing housing equipment rental services.

ISIN
TW0006814007
Founded
2002
Listed since
Dec 31, 2020
Exchange
Taipei Exchange
Currency
TWD
CompanyMarket capPriceDay
Immutep LimitedASX: IMM$24.85MAU$0.02+4.35%
Genvor IncorporatedOTCPK: GNVR$24.85M$0.68-24.17%
Thiogenesis Therapeutics, Corp.TSXV: TTI$24.74MCA$0.50-5.66%
Seres Therapeutics, Inc.NasdaqGS: MCRB$24.71M$2.46-9.23%
Original BioMedicals Co., Ltd.TPEX: 6483$24.50MNT$11.90+3.93%
Ribomic Inc.TSE: 4591$24.36M¥68.00-4.23%
Polyrizon Ltd.NasdaqCM: PLRZ$24.29M$10.00+11.26%
Shuttle Pharmaceuticals Holdings, Inc.NasdaqCM: SHPH$24.20M$5.08-4.69%

Browse every Biotechnology company →

Figures last refreshed Oct 18, 2026.